Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. The company is headquartered in Pleasanton, California.
| Revenue (TTM) | $3.32B |
| Gross Profit (TTM) | $2.49B |
| EBITDA | $1.03B |
| Operating Margin | 30.90% |
| Return on Equity | 13.90% |
| Return on Assets | 7.30% |
| Revenue/Share (TTM) | $20.26 |
| Book Value | $44.83 |
| Price-to-Book | 4.29 |
| Price-to-Sales (TTM) | 9.21 |
| EV/Revenue | 7.26 |
| EV/EBITDA | 24.21 |
| Quarterly Earnings Growth (YoY) | 14.60% |
| Quarterly Revenue Growth (YoY) | 16.30% |
| Shares Outstanding | $162.44M |
| Float | $148.97M |
| % Insiders | 8.58% |
| % Institutions | 89.60% |
Volatility is currently contracting
Recently, Zacks.com users have been paying close attention to Veeva (VEEV). This makes it worthwhile to examine what the stock has in store.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Veeva (VEEV) reported earnings 30 days ago. What's next for the stock?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
VEEV expands its AI push with Copli acquisition and Falcon MLR launch, aiming to speed life sciences content reviews and boost Commercial Cloud.
VEEV's Veeva EHS expands Quality Cloud with automated risk, compliance and safety workflows, aiming to replace legacy systems with a unified platform.
Veeva Systems trades at 17x FY2027 earnings, offering high margins and recurring revenue, yet faces slowing Commercial CRM growth and strong competition. R&D and Quality segments now outpace Commercial, growing 19% in Q1 FY2027 and becoming the largest revenue driver, deeply embedded in regulated customer processes. VEEV's moat is strong due to switching costs and integrated solutions, but not unassailable—Salesforce, Oracle, and others remain credible threats.
Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Environmental, health, and safety solution is part of Veeva Quality Cloud and will deliver real-time insights and streamlined workflows PLEASANTON, Calif., June 25, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva EHS, a new application in Veeva Quality Cloud for environmental, health, and safety.
Veeva Systems remains a Buy, with core revenue and subscription growth in the mid-teens and a compelling ~16x NTM PE valuation. Falcon, VEEV's agentic labor AI platform, makes the AI opportunity tangible, offering automation for compliance-sensitive, high-volume workflows in life sciences. R&D and Quality subscription revenue outpaces consolidated growth at 19% y/y, while Commercial gains traction with over 150 live Vault CRM customers.
